Vault-13

NEUROSENSE THERAPEUTICS LTD NRSNW

*W EXP 11/10/202 · Equity WRT · CUSIP M74240116

3 institutional holders +0 vs Q1 2026
164,650164.7k shares reported held*
$10.4kreported value*
0 new 0 added 1 reduced 0 sold out net sold ≈ $19 (-300 shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.06.

Trends to Q2 2026

Institutional holders

Managers reporting a position, each quarter

0258Q3 22: 6Q4 22: 5Q1 23: 5Q2 23: 6Q3 23: 7Q4 23: 4Q1 24: 5Q2 24: 5Q3 24: 5Q4 24: 5Q1 25: 4Q2 25: 3Q3 25: 2Q4 25: 3Q1 26: 3Q2 26: 33Q3 22Q3 23Q3 24Q3 25Q2 26
Numbers
QuarterHolders
Q3 20226
Q4 20225
Q1 20235
Q2 20236
Q3 20237
Q4 20234
Q1 20245
Q2 20245
Q3 20245
Q4 20245
Q1 20254
Q2 20253
Q3 20252
Q4 20253
Q1 20263
Q2 20263

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
404Q3 24: 1 bought or addedQ3 24: 3 cut or sold outQ4 24: 0 bought or addedQ4 24: 4 cut or sold outQ4 24Q1 25: 2 bought or addedQ1 25: 2 cut or sold outQ2 25: 0 bought or addedQ2 25: 3 cut or sold outQ2 25Q3 25: 0 bought or addedQ3 25: 1 cut or sold outQ4 25: 0 bought or addedQ4 25: 2 cut or sold outQ4 25Q1 26: 0 bought or addedQ1 26: 0 cut or sold outQ2 26: 0 bought or addedQ2 26: 1 cut or sold outQ2 26
Numbers
QuarterBought or addedCut or sold out
Q3 202413
Q4 202404
Q1 202522
Q2 202503
Q3 202501
Q4 202502
Q1 202600
Q2 202601

Biggest buyers

None

Biggest sellers

Clear Street Group Inc. Reduced -300-300

Insider purchases and sales since 1 Apr 2026

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

Officers and directors buying vs selling

Number of people, by quarter (10% owners not included)

BuyingSelling
202Q4 24: 0 buyingQ4 24: 0 sellingQ1 25: 0 buyingQ1 25: 0 sellingQ1 25Q2 25: 0 buyingQ2 25: 0 sellingQ3 25: 0 buyingQ3 25: 0 sellingQ3 25Q4 25: 0 buyingQ4 25: 0 sellingQ1 26: 0 buyingQ1 26: 0 sellingQ1 26Q2 26: 2 buyingQ2 26: 0 sellingQ3 26: 0 buyingQ3 26: 0 sellingQ3 26
Numbers
QuarterBuyingBoughtSellingSoldSold under a plan
Q4 20240—0——
Q1 20250—0——
Q2 20250—0——
Q3 20250—0——
Q4 20250—0——
Q1 20260—0——
Q2 20262$200.0k0——
Q3 20260—0——
DateInsiderTradeSharesPrice ValueTheir holding
2026-06-16 Eisenberg Or Chief Financial Officer Bought 250,000 $0.80 $200.0k250.0k shares +20%
2026-06-16 Ben-Noon Alon Chief Executive Officer Bought 250,000 $0.80 $200.0k250.0k shares +6%

Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).

Holders, Q2 2026

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Empery Asset Management, LP 0.01% of their portfolio NEW YORK, NY 100,402100.4k $6.3k $6.3k 0.01% Unchanged
2 Clear Street Group Inc. 0.00% of their portfolio NEW YORK, NY 63,08563.1k $4.0k $4.0k 0.00% Reduced -300 -300
3 UBS Group AG 0.00% of their portfolio ZURICH, V8 1,1631.2k $73 $73 0.00% Unchanged